Owen N. Witte
CIK: 0001700969
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ALLO
Allogene Therapeutics, Inc.
Director
Discretionary Trading P&L
Holdings
About WITTE OWEN N.
WITTE OWEN N. (SEC CIK 0001700969) files insider reports with the SEC as Director of Allogene Therapeutics, Inc. (ALLO).
Signal8 holds 2 ownership filings by WITTE OWEN N., all Form 4s, filed between Jun 23, 2025 and Jun 23, 2026. Those filings report 2 transactions, from Jun 18, 2025 to Jun 18, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on WITTE OWEN N.'s filings is in SOUTH SAN FRANCISCO, CA.
Recent filings by WITTE OWEN N.
Other insiders filing for Allogene Therapeutics, Inc. (ALLO)
- Parker Geoffrey M., CHIEF FINANCIAL OFFICER
- Douglas Earl Martin, SVP, General Counsel
- Roberts Zachary, President and CEO
- Kazam Joshua A, Director
- MESSEMER DEBORAH M., Director
- Mayo Stephen, Director